Display Settings:

Format

Send to:

Choose Destination
Am J Obstet Gynecol. 2013 Apr;208(4):318.e1-7. doi: 10.1016/j.ajog.2013.01.012. Epub 2013 Jan 10.

Amniotic fluid induces platelet-neutrophil aggregation and neutrophil activation.

Author information

  • 1Department of Anesthesiology, China Medical University Hospital, Taichung, Republic of China.

Abstract

OBJECTIVE:

Amniotic fluid embolism syndrome is a fatal disease in pregnant women. The exact role of platelets and neutrophils in amniotic fluid embolism syndrome is not clear. We examined whether amniotic fluid could affect platelet-neutrophil aggregation and activation and the possible mechanisms.

STUDY DESIGN:

Blood samples from the pregnant women were pretreated ex vivo with their own amniotic fluid. Flow cytometry was used to measure platelet-neutrophil aggregation and activation. Neutrophil-mediated activity of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinases 1 and 2 was analyzed by Western blotting.

RESULTS:

Amniotic fluid significantly induced platelet-neutrophil aggregation, neutrophil CD11b expression, and reactive oxygen species production. Amniotic fluid induced minimal platelet P-selectin expression. The increase of intracellular calcium level of neutrophils and the activity of p38 mitogen-activated protein kinase were enhanced by amniotic fluid stimulation.

CONCLUSION:

Amniotic fluid was able to induce neutrophil activation and platelet-neutrophil aggregation with minimal effect on platelet activation. These findings may provide a new insight in the understanding of the pathophysiologic condition of amniotic fluid embolism syndrome.

Copyright © 2013 Mosby, Inc. All rights reserved.

PMID:
23313310
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk